# ANDA220421
> **ANDA220421** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LIMITED, VEMAGAL · Approved 2026-05-01
## Drug
- **FDA Application Number:** ANDA220421
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** —
- **Generic name:** —
- **Active ingredients:** —
- **Dosage form:** —
- **Route:** —
- **Marketing status:** —
- **Sponsor:** HETERO LABS LIMITED, VEMAGAL
- **First approval:** 2026-05-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220421)
---
*MORVS · CC0 1.0*